::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

CLINICAL OUTCOMES OF CORONARY ARTERY BYPASS GRAFT AND ITS EFFECTS IN MORTALITY AND MORBIDITY RATES

AUTHORS:

Dr. Abrar Wazzan *, Arwa Hakami , Bashair Madkhali , Walaa Hakami , Ola Sumayli , Tasneem Mobarki , Kholoud Assiri , Asmaa Zanquti , Shareefa Somaily , Afaf Jaafari , Areej Areeshi ,Mohammed Omair , Meshari Alshehri , Dhafer Alshehri

ABSTRACT:

This review article summarizes the major studies performed to show the clinical outcomes of coronary artery bypass graft surgery (CABG), including the history of CABG, indications, measurement of quality of life after CABG in addition to complications to surgery such as life prolongation, physical functioning which can be tested through relief of angina and dyspnea and improvement of physical activity. Coronary artery bypass surgery remains an established form of treatment for coronary artery disease, and the majority of coronary surgical procedures are performed for multiple vessel disease. As for the mortality rates: It was found that the mortality rate of coronary artery surgery is low, at around 2%–3%, although this benefit is offset by a complication rate of 20%–30%. In this article we are going to determine the clinical outcomes of CABG in different patients and how does CABG affect the mortality and morbidity rates in these patients.Therefore, in addition to studying mortality and morbidity outcomes following CABG, many recent studies have identified that it is important to investigate various physical, psychological, and social variables that have a significant impact on post-operative adjustment to CABG. Key words: CABG, Mortality, Morbidity.